Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT02264756
Eligibility Criteria:
Inclusion Criteria:
* have a positive Febrile Respiratory Illness (FRI) screen on admission to hospital (http://www.health.gov.on.ca/fr/public/programs/emu/sars/reports/dir\_122303\_acute\_care\_nonoutbreak.pdf)
* diagnosed with pneumonia by the admitting physician (Acute exacerbations of chronic obstructive lung disease are considered within the definition of pneumonia for the purposes of this study as they are commonly treated with the same antimicrobial regimens as patients with pneumonia)
* admitted to a medical ward
Exclusion Criteria:
* hospitalized for ≥ 48 consecutive hours in the preceding 3 months
* receiving immunosuppressants \[defined as ≥ 40 mg prednisone daily (or steroid equivalent) for ≥ 2 weeks preceding hospitalization OR any other immunosuppressant used for systemic illness OR to prevent transplant rejection\]
* neutropenic \[defined as a polymorphonuclear count ≤ 0.5 x 109 cells/L\] from any cause
* immunocompromised \[defined as having leukemia, lymphoma, HIV with CD4 cell count ≤ 200, splenectomy or on cytotoxic chemotherapy\]
* admitted to high acuity units such as intensive care units
* require mechanical ventilation, either non-invasive or invasive
* have a life expectancy of ≤ 3 months (palliative)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02264756
Study Brief:
Protocol Section:
NCT02264756